OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Sequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma

Cancer Research Funding: Underfunded or Unequally Distributed?

A Living Library of Cancer: New Models Could Help Researchers Find Better Treatments

Patient Advocate Training Opportunity

Metastatic Renal Cell Carcinoma in 2026: Frontline Combinations, Post-IO Sequencing, and the Emergence of HIF-2α Inhibition

Oncology News, Insights, Stories by OncoDaily

Replimune Tudriqev
Oncology Tech

Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma

CancerWorld
Voices

Who Will Write the Next Chapter of Oncology? – CancerWorld

ORR vs OS: The Debate Continues on X
Not To Miss

ORR vs OS: The Debate Continues on X

PRODIGE-24/CCTG PA6: Tumor Genomics and Adjuvant Chemotherapy in Resected Pancreatic Cancer

Archie Goodburn: Defying Oligodendroglioma While Racing for the Future of Brain Cancer Care

Joshua Brody: New Combination Therapy Achieves 96% Remission in Follicular Lymphoma

Paolo Ascierto Receives the 2026 SITC Lifetime Achievement Award

CReDO Workshop 2027 Applications Open Until 15 August 2026

Todd Harper: Cancer Council Victoria Calls for Bold Investment to Transform Cancer Care Ahead of 2026 Election

Brooke Shields: From Hollywood Icon to Powerful Skin Health Advocate

Voices
Karen Canfell

Karen Canfell: A New Strategic Framework for Australia’s BreastScreen Program

Gevorg Tamamyan: Registration Open for OncoDaily and PICI's IMMUNÕ 2026 Virtual Congress

Zainab Shinkafi-Bagudu Congratulates Aisha Mustapha on Being Elected Chairman of the Nigerian Medical Association

Guillermo Chantada: One of the Most Rewarding Things I Have Ever Done

Vincent Rajkumar: Genomics Alone Is Not Great at Predicting Outcome in Smoldering Myeloma

7th Emirates Oncology Society Annual Conference 2026 Set to Bring Together Oncology Experts in Dubai

Chinmay Jani: AYA Lung Cancer Is Not the Same as Traditional NSCLC

FDA Approvals
FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Grants Priority Review to RYBREVANT FASPRO After Promising 42% Response in Head and Neck Cancer

FDA Approved Subcutaneous Isatuximab: Advancing Anti-CD38 Therapy Delivery in Multiple Myeloma

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz, the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

OncoDaily 100
100 Influential People in Oncology

100 Influential People in Oncology 2026 – Nominations are Open!

100 Influential Cancer Survivors on Social Media: 2026 Edition

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Celebrities and Cancer

OncoCalendar

The 2026 International Kidney Cancer Symposium (IKCS)

Kidney Cancer Association

19 Nov
Kidney Cancer Symposium

The CAMO 2026 Annual Scientific Meeting

Canadian Association of Medical Oncologists (CAMO)

05 Nov
CAMO 2026

Kidney Week 2026

American Society of Nephrology (ASN)

21 Oct
Kidney Week 2026

JADPRO Live 2026

Advanced Practitioner Society for Hematology and Oncology (APSHO)

15 Oct
JADPRO

The IGCS 2026 Annual Global Meeting

International Gynecologic Cancer Society

01 Oct
IGCS 2026

Immune-oncology
Sequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma

Sequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma

Can Diet and the Gut Microbiome Improve Immunotherapy Response?

Tumor Mutational Burden Predicts Response to Neoadjuvant Immunotherapy

CRISPR in Cancer Immunotherapy and Precision Oncology

Predicting Immunotherapy Response Beyond PD-L1 and Tumor Mutational Burden

Perioperative Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma

Artificial Intelligence in Cancer Immunotherapy

Gastrointestinal-Oncology
PRODIGE-24/CCTG PA6

PRODIGE-24/CCTG PA6: Tumor Genomics and Adjuvant Chemotherapy in Resected Pancreatic Cancer

EvIDHence Study: Real-World Outcomes in IDH1-Mutant and Wild-Type Cholangiocarcinoma Before mIDH1 Inhibitors

FDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer

ctDNA in Gastrointestinal Cancers: What the Evidence Shows

DESTINY-PanTumor02: T-DXd in HER2-Expressing Biliary Tract or Pancreatic Cancers

10 Must-Read Posts In GI Oncology This Week

Claudin 18.2 and FGFR2b: New Biomarkers in Gastric and Esophageal Cancer

Breast-Oncology
Neratinib

Patient-Reported GI Toxicity Reveals Hidden Burden With Neratinib Plus T-DM1

Tumor-Derived Extracellular Vesicles Reveal Hidden MBC Risk

HORIZON-Breast01: Trastuzumab Rezetecan Delivers 30.6-Month PFS

SUPREMO: Chest Wall Radiotherapy Has Limited 5-Year QOL Impact

FeDeriCa: 4-Year Outcomes Support Subcutaneous HER2 Therapy

TROPION-Breast01 Details Dato-DXd Safety and Patient-Reported Outcomes

EVERGREEN Study: Everolimus Shows Modest Benefit After CDK4/6 Progression

Lung-Oncology
HER2 Mutations

HER2 Mutations in NSCLC: Critical Risks of Outdated Terms

EGFR Amplification in EGFR-Mutated NSCLC: Critical Risk Marker

Lung Cancer in Nonsmoking Individuals: A Distinct Clinical Profile

TREASURE Trial Raises Safety Concerns for Thoracic Radiotherapy With Atezolizumab in ES-SCLC

Phase 2 Study Evaluates BIO 300 With SBRT in Early-Stage NSCLC and ILD

89 Experts Map Key Gray Zones in Non-Metastatic NSCLC

Molecular Testing Turnaround Before First-Line Therapy in Advanced NSCLC

Oncology Tech
Replimune Tudriqev

Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma

AstraZeneca-Bristol Myers Merger Denied: What It Exposed

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring

FDA approves GSK's Jideytro for previously treated ROS1-positive NSCLC, the company's first lung cancer clearance

Third Time at the Table: Why Replimune's RP1 Deserves a Real Hearing in Post-PD-1 Melanoma

James Hadfield: Emerging Technologies Aim to Democratize Ultra-Sensitive MRD Testing

The radiopharmaceutical land grab — and the isotope bottleneck no one's pricing in

Hematology
EMD Multiple Myeloma

Extramedullary Disease in Multiple Myeloma (EMD): Progress in the Immunotherapy Era

Access to TCRTs in Multiple Myeloma: Patient, Caregiver, and Physician Perspectives

Autologous Stem Cell Transplantation (ASCT) for HIV-Associated Lymphoma: Latest Evidence

BTK Inhibitors in Chronic Lymphocytic Leukemia: Current Practice and Future Perspectives

Systemic Mastocytosis: A Hematologic Neoplasm Often Mistaken for Allergy and Other Conditions

Leukemia Diagnosis: Every Step From First Symptoms to Treatment and Beyond

Prognostic Scores and Risk Stratification in Myeloproliferative Neoplasms (MPN): 2026 Updates

Radiotherapy
Nodal Radiotherapy

One-Week Regional Nodal Radiotherapy Preserves Quality of Life in Breast Cancer

10 Must-Read Posts In Radiotherapy This Week: July 27- August 2

E2-RADIatE Shows How Prospective Registries Can Strengthen Radiation Oncology Research

IMPulse Trial Tests FLASH Radiotherapy for Melanoma Skin Metastases

Shorter Locoregional Radiotherapy Matches Standard Treatment in High-Risk Breast Cancer

Adaptive MR-Guided SBRT Shows Low Toxicity in Prostate Cancer

10 Must-Read Posts In Radiotherapy This Week: July 20-26

OncoDaily TV
Nirmala Bhoo-Pathy

Nirmala Bhoo-Pathy: How to Translate Scientific Breakthroughs into Real-world Benefits

The Man Who Built Elekta: Larry Leksell

The Man Who Built Elekta: Larry Leksell

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

Empowering Oncologists: Why is Patient Navigation Critically Important in Cancer Care

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

How One Doctor Helped Transform Cancer Care in New Zealand: Dr. Christopher Jackson

World Health Voices

Is US Still a WHO Member? World Health Voices Interview with Prof. Lawrence O. Gostin

Antonio Jimenez (2)

Antonio Jimenez Jimenez: A Powerful Reminder of Why NMDP Work Matters

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

Can Research Funding Save More Lives: Dr. Kimberly Sabelko Explains

lisa-thompson-smith-reimbursemement

The System Behind Access of New Cancer Drugs with Lisa Thompson Smith

Elas Sharon, Med News Week

Navigating the Intersection of Immunotherapy and Autoimmunity Dr. Elad Sharon

Rodrigo Sánchez-Bayona open doors

What Makes a Great Oncologist? Insights from Dr. Rodrigo Sánchez-Bayona

Daraxonrasib for Pancreatic Cancer: What’s Next?

Daraxonrasib for Pancreatic Cancer: What’s Next?

1000 doctors standing asco alan sandler

Why 1000 Doctors Gave This Cancer Drug A Standing Ovation?

Not To Miss
CReDO Workshop 2027

CReDO: Where Oncology Research Ideas Become Research Protocols

World Cancer Support Month: Support Beyond Cancer Treatment 2026

FDA Grants Accelerated Approval to Tudriqev Plus Nivolumab for Advanced Melanoma

ORR vs OS: The Debate Continues on X

A Living Library of Cancer: New Models Could Help Researchers Find Better Treatments

FDA Held Webinar on Proposed Path to Faster First-in-Human Trials

CReDO Workshop 2027 Applications Open Until 15 August 2026

OncoGrants
Palliative Care Grant

Horizon Europe Earlier and More Precise Palliative Care Grant 2026

Research Grant

Robert L. Fine Cancer Research Foundation Research Grant 2026

CRI

CRI Technology Impact Award 2026

Leukemia/Lymphoma Fellowship

High-Risk Leukemia/Lymphoma Fellowship 2027

Lymphoma Research

Lymphoma Research Foundation Clinical Investigator Career Development Award 2027

Gastric Cancer

AGA-R. Robert & Sally Funderburg Research Award in Gastric Cancer

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Non-Hodgkin Lymphoma NHL, DLBCL

Non-Hodgkin Lymphoma (NHL): A Practical Biological Map and Integrative Overview

Mantle Cell Lymphoma (MCL): Revealing the Biology Beneath the Mantle and Modern Therapeutic Frontiers

Burkitt Lymphoma: Among the Fastest Growing Yet Most Curable Human Cancers

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

CancerWorld

Oncologists
Douglas Flora

Douglas Flora

Oncologists Location Edgewood, USA
Leandro Jonata de Carvalho Oliveira

Leandro Jonata de Carvalho Oliveira

Oncologists Location São Paulo, Brazil
Charbel Matar

Charbel Matar

Oncologists Location Washington, USA
Roupen Odabashian

Roupen Odabashian

Oncologists Location Detroit, USA
Rachna Shroff

Rachna Shroff

Oncologists Location Tucson, USA
Alberto Puccini

Alberto Puccini

Oncologists Location Milan, Italy
Gabriele Todisco

Gabriele Todisco

Oncologists Location Milan, Italy
Cristina Smolenschi

Cristina Smolenschi

Oncologists Location Villejuif, France

Oncology Drugs
Fianlimab: Mechanism, Dose, Administration, And Clinical Trials

Fianlimab: Mechanism, Dose, Administration, And Clinical Trials

DKN-01: Promising DKK1-Targeted Therapy, Dose, Administration, and Clinical Trials

Ponsegromab: Mechanism, Clinical Trials, Presented Data, and Future Role in Cancer Cachexia

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

OncoDaily Magazine

New Paper Alert
Rodrigo Lastra del Prado

Rodrigo Lastra del Prado: Benefits of Empathetic Oncologist Patient Communication

ICRA trial

The ICRA trial: Paclitaxel Plus Tremelimumab Shows Activity After Platinum and PD-(L)1 Therapy in Metastatic Urothelial Cancer

Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

OncoDaily Medical Journal

Oncology Nursing

10.69690/ODMJ-012-0826-7730

Chronic illness trajectory of patients with multiple myeloma derived from health-related quality of life data – an integrative review
Systematic Reviews & Meta Analysis

Public Health

10.69690/ODMJ-002-0726-7335

From Evidence to Impact: Multilevel Strategies for Cancer Prevention in Europe
Reviews

Oncology Nursing

10.69690/ODMJ-011-0626-7610

Major oral hemorrhage after tongue cancer surgery: A case report
Case Reports & Case Series

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports & Case Series

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries